Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life…
An institutional-grade, numbers-driven thesis on DHR — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates Danaher Corporation (DHR) 54/100 with a 12-month base-case forecast of $210.07 — +2.6% versus the current price of $204.76. Danaher Corporation trades at $204.76 in the Healthcare sector. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for DHR is $210.07, implying +2.6% versus the current price. The model's 12-month scenario range runs from $180.64 (bear) to $253.17 (bull), with a base case of $210.07.
On the fundamentals, Danaher shows trailing revenue of $24.57B. This page also tracks DHR's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
DHR currently carries a TradersQuant composite score of 54/100, which we read as a neutral-to-watch signal. Our 12-month price target of $210.07 implies +2.6% from $204.76. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for DHR is $210.07, about +2.6% versus the latest price of $204.76.
TradersQuant's 12-month model forecast for DHR is a base case of $210.07, ranging from $180.64 (bear) to $253.17 (bull), an expected return of +2.6%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for DHR over the next 12 months is $210.07 in the base case (bear $180.64, bull $253.17), versus today's price of $204.76. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for DHR — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates DHR's fair value at $260.25, implying +27.1% of expected upside versus the current price.
Danaher does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
